Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis

Open access

Abstract

A combination of hyperthermia with radiotherapy and chemotherapy for various solid tumors has been practiced clinically. However, hyperthermic therapy has side effects, such as thrombocytopenia. Up to now, the pathogenesis of hyperthermia-induced thrombocytopenia remains unclear. Previous studies have shown that hyperthermia induces platelet apoptosis. However, the signaling pathways and molecular mechanisms involved in hyperthermia-induced platelet apoptosis have not been determined. Here we show that hyperthermia induced intracellular reactive oxygen species (ROS) production and mitochondrial ROS generation in a time-dependent manner in platelets. The mitochondria-targeted ROS scavenger Mito-TEMPO blocked intracellular ROS and mitochondrial ROS generation. By contrast, inhibitors of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, nitric oxide synthase, cyclooxygenase and lipoxygenase did not. Furthermore, Mito-TEMPO inhibited hyperthermia-induced malonyldialdehyde production and cardiolipin peroxidation. We also showed that hyperthermia-triggered platelet apoptosis was inhibited by Mito-TEMPO. Furthermore, Mito-TEMPO ameliorated hyperthermia-impaired platelet aggregation and adhesion function. Lastly, hyperthermia decreased platelet manganese superoxide dismutase (MnSOD) protein levels and enzyme activity. These data indicate that mitochondrial ROS play a pivotal role in hyperthermia-induced platelet apoptosis, and decreased of MnSOD activity might, at least partially account for the enhanced ROS levels in hyperthermia-treated platelets. Therefore, determining the role of mitochondrial ROS as contributory factors in platelet apoptosis, is critical in providing a rational design of novel drugs aimed at targeting mitochondrial ROS. Such therapeutic approaches would have potential clinical utility in platelet-associated disorders involving oxidative damage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0075044

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mitochondria are the major sources of ROS in hyperthermia-treated platelets. (A and B) DCFDA-loaded platelets were incubated at the indicated temperatures for 3 h (A) or 1-3 h (B). As a positive control, loaded platelets were incubated with thrombin at 37°C for 30 min. Samples were then analyzed for intracellular ROS levels by flow cytometry. Representative flow cytometric histogram is shown (A). The relative ROS levels are expressed as a percentage of platelets, which were incubated at RT for 1 h (B). Percentage of RT 1h is presented as mean ± SEM from three independent experiments. *P<0.017 (after Bonferroni correction) as compared with RT 1 h, **P<0.017 (after Bonferroni correction) as compared with RT 2 h, #P<0.017 (after Bonferroni correction) as compared with RT 3h. (C–E) DCFDA-loaded platelets were pre-incubated with solvent control, DPI and apocynin (C), Mito-TEMPO and NAC (D), or L-NAME and ETYA (E) at 37 °C for 15 min, and then incubated for 3 h at 40°C or 42°C, and further analyzed by flow cytometry. The relative ROS levels are expressed as a percentage of platelets, which were pre-incubated with solvent control at 37°C for 15 min and then incubated at 40°C for 3 h. Percentage of 40°C loaded platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.025 (after Bonferroni correction) as compared with solvent control at 40°C, **P<0.025 (after Bonferroni correction) as compared with solvent control at 42°C. Thrombin is labeled as Thr.
Figure 1 Mitochondria are the major sources of ROS in hyperthermia-treated platelets. (A and B) DCFDA-loaded platelets were incubated at the indicated temperatures for 3 h (A) or 1-3 h (B). As a positive control, loaded platelets were incubated with thrombin at 37°C for 30 min. Samples were then analyzed for intracellular ROS levels by flow cytometry. Representative flow cytometric histogram is shown (A). The relative ROS levels are expressed as a percentage of platelets, which were incubated at RT for 1 h (B). Percentage of RT 1h is presented as mean ± SEM from three independent experiments. *P<0.017 (after Bonferroni correction) as compared with RT 1 h, **P<0.017 (after Bonferroni correction) as compared with RT 2 h, #P<0.017 (after Bonferroni correction) as compared with RT 3h. (C–E) DCFDA-loaded platelets were pre-incubated with solvent control, DPI and apocynin (C), Mito-TEMPO and NAC (D), or L-NAME and ETYA (E) at 37 °C for 15 min, and then incubated for 3 h at 40°C or 42°C, and further analyzed by flow cytometry. The relative ROS levels are expressed as a percentage of platelets, which were pre-incubated with solvent control at 37°C for 15 min and then incubated at 40°C for 3 h. Percentage of 40°C loaded platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.025 (after Bonferroni correction) as compared with solvent control at 40°C, **P<0.025 (after Bonferroni correction) as compared with solvent control at 42°C. Thrombin is labeled as Thr.CC BY · PubMed Central
Figure 2 Hyperthermia increase mitochondrial superoxide production. (A and B) MitoSOXTM Red-loaded platelets were incubated at the indicated temperatures for 3 h (A) or1-3 h (B). As a positive control, loaded platelets were incubated with antimycin A at 37°C for 30 min. Samples were then analyzed by flow cytometry. Representative flow cytometric histogram is shown (A). Data are expressed as a percentage of platelets which were incubated at RT for 1h (B). Percentage of RT 1h is presented as mean ± SEM from three independent experiments. *P<0.017 (after a Bonferroni correction) compared with RT 1 h, **P<0.017 (after Bonferroni correction) as compared with RT 2 h, #P<0.017 (after Bonferroni correction) as compared with RT 3 h. (C) MitoSOXTM Red-loaded platelets were pre-incubated with apocynin, Mito-TEMPO, L-NAME, ETYA, or solvent control at 37°C for 15 min, and then incubated for 3 h at 40°C or 42°C, and further analyzed by flow cytometry. Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at 40°C for 3 h. Percentage of 40°C platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.013 (after Bonferroni correction) as compared with solvent control at 40°C, **P<0.013 (after Bonferroni correction) as compared with solvent control at 42°C. Antimycin A is labeled as Ant.
Figure 2 Hyperthermia increase mitochondrial superoxide production. (A and B) MitoSOXTM Red-loaded platelets were incubated at the indicated temperatures for 3 h (A) or1-3 h (B). As a positive control, loaded platelets were incubated with antimycin A at 37°C for 30 min. Samples were then analyzed by flow cytometry. Representative flow cytometric histogram is shown (A). Data are expressed as a percentage of platelets which were incubated at RT for 1h (B). Percentage of RT 1h is presented as mean ± SEM from three independent experiments. *P<0.017 (after a Bonferroni correction) compared with RT 1 h, **P<0.017 (after Bonferroni correction) as compared with RT 2 h, #P<0.017 (after Bonferroni correction) as compared with RT 3 h. (C) MitoSOXTM Red-loaded platelets were pre-incubated with apocynin, Mito-TEMPO, L-NAME, ETYA, or solvent control at 37°C for 15 min, and then incubated for 3 h at 40°C or 42°C, and further analyzed by flow cytometry. Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at 40°C for 3 h. Percentage of 40°C platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.013 (after Bonferroni correction) as compared with solvent control at 40°C, **P<0.013 (after Bonferroni correction) as compared with solvent control at 42°C. Antimycin A is labeled as Ant.CC BY · PubMed Central
Figure 3 Effect of Mito-TEMPO on the levels of MDA and cardiolipin peoxidation in hyperthermia-treated platelets. (A and B) Washed platelets were incubated without (A), or with (B) Mito-TEMPO and solvent control at 37°C for 15 min, and then incubated at different temperatures for 3 h. MDA levels were detected as described in Methods. (C–E) Washed platelets were incubated without (C and D), or with (E) Mito-TEMPO and solvent control at 37°C for 15 min, and then incubated at different temperatures for 3 h. Cardiolipin peoxidation was detected as described in Methods. Representative flow cytometric histogram is shown (C). (A and D) Data are expressed as a percentage of platelets which were incubated at RT for 3h. Percentage of RT is presented as mean ± SEM from three independent experiments. *P<0.017 (after Bonferroni correction) as compared with RT. (B and E) Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at RT for 3 h. Percentage of RT platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.05 as compared with solvent control at an identical temperature.
Figure 3 Effect of Mito-TEMPO on the levels of MDA and cardiolipin peoxidation in hyperthermia-treated platelets. (A and B) Washed platelets were incubated without (A), or with (B) Mito-TEMPO and solvent control at 37°C for 15 min, and then incubated at different temperatures for 3 h. MDA levels were detected as described in Methods. (C–E) Washed platelets were incubated without (C and D), or with (E) Mito-TEMPO and solvent control at 37°C for 15 min, and then incubated at different temperatures for 3 h. Cardiolipin peoxidation was detected as described in Methods. Representative flow cytometric histogram is shown (C). (A and D) Data are expressed as a percentage of platelets which were incubated at RT for 3h. Percentage of RT is presented as mean ± SEM from three independent experiments. *P<0.017 (after Bonferroni correction) as compared with RT. (B and E) Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at RT for 3 h. Percentage of RT platelets pre-incubated with solvent control is presented as mean ± SEM from three independent experiments. *P<0.05 as compared with solvent control at an identical temperature.CC BY · PubMed Central
Figure 4 Effect of Mito-TEMPO on Bax mitochondrial translocation and cytochrome C release in hyperthermia-treated platelets. (A–D) Washed platelets were incubated at different temperatures for 3 h (A and B), or pre-incubated with Mito-TEMPO and solvent control at 37°C for 15 min and then incubated at 42°C for 3 h (C and D). Treated platelets were lysed, and cytosol and mitochondrial fractions were isolated and analyzed by Western blot with anti-Bax (A and C), and anti-cytochrome C (B and D). Cytochrome C oxidase subunit 1 (COX1) and tubulin were used as internal controls. Representative data of three independent experiments are presented. Cytochrome C is labeled as Cyto C.
Figure 4 Effect of Mito-TEMPO on Bax mitochondrial translocation and cytochrome C release in hyperthermia-treated platelets. (A–D) Washed platelets were incubated at different temperatures for 3 h (A and B), or pre-incubated with Mito-TEMPO and solvent control at 37°C for 15 min and then incubated at 42°C for 3 h (C and D). Treated platelets were lysed, and cytosol and mitochondrial fractions were isolated and analyzed by Western blot with anti-Bax (A and C), and anti-cytochrome C (B and D). Cytochrome C oxidase subunit 1 (COX1) and tubulin were used as internal controls. Representative data of three independent experiments are presented. Cytochrome C is labeled as Cyto C.CC BY · PubMed Central
Figure 5 Effect of Mito-TEMPO on caspase-3 activation, depolarization of ΔΨm, and PS exposure in hyperthermia-treated platelets. (A and B) Washed platelets were incubated at indicated temperatures for 3 h (A) or pre-incubated with Mito-TEMPO and solvent control at 37°C for 15 min and then incubated at 42°C for 3 h (B). Treated platelets were lysed and analyzed by Western blot with anti-cleaved p17 fragment of caspase-3. Actin levels were assayed to demonstrate equal protein loading. Representative results of three independent experiments are presented. (C–F) Washed platelets were pre-incubated without (C and D) or with Mito-TEMPO and solvent control at 37°C for 15 min (E and F), and then incubated at the indicated temperature for 3 h. Treated platelets were incubated with TMRE (C and E), or annexin V-FITC (D and F), and analyzed by flow cytometry. Representative flow cytometric histograms are shown (C and D). Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at RT for 3 h (E and F). The percentage of RT platelets pre-incubated with solvent is presented as mean ± SEM from three independent experiments. *P<0.05 as compared with solvent control at an identical temperature.
Figure 5 Effect of Mito-TEMPO on caspase-3 activation, depolarization of ΔΨm, and PS exposure in hyperthermia-treated platelets. (A and B) Washed platelets were incubated at indicated temperatures for 3 h (A) or pre-incubated with Mito-TEMPO and solvent control at 37°C for 15 min and then incubated at 42°C for 3 h (B). Treated platelets were lysed and analyzed by Western blot with anti-cleaved p17 fragment of caspase-3. Actin levels were assayed to demonstrate equal protein loading. Representative results of three independent experiments are presented. (C–F) Washed platelets were pre-incubated without (C and D) or with Mito-TEMPO and solvent control at 37°C for 15 min (E and F), and then incubated at the indicated temperature for 3 h. Treated platelets were incubated with TMRE (C and E), or annexin V-FITC (D and F), and analyzed by flow cytometry. Representative flow cytometric histograms are shown (C and D). Data are expressed as a percentage of platelets that were pre-incubated with solvent control at 37°C for 15 min and then incubated at RT for 3 h (E and F). The percentage of RT platelets pre-incubated with solvent is presented as mean ± SEM from three independent experiments. *P<0.05 as compared with solvent control at an identical temperature.CC BY · PubMed Central
Figure 6 Mito-TEMPO ameliorates hyperthermia-impaired platelet function. (A) Platelet aggregation was performed as described in Methods. Representative traces from three independent experiments are shown. (B and C) Washed platelets were incubated at the indicated temperatures for 3 h (B), or pre-incubated with Mito-TEMPO, GM6001 and solvent control at 37°C for 15 min, followed by incubation at 42°C for 3 h (C). Western blot was performed as described in Methods. (D and E) Washed platelets were incubated at indicated temperatures for 3 h (D), or pre-incubated without (control) or with Mito-TEMPO and solvent at 37°C for 15 min, and then incubated at 42°C for 3 h (E). Platelet adhesion was performed as described in Methods. The results shown are the mean ± SEM of cell number/mm2. *P<0.017 (after Bonferroni correction) as compared with RT, **P<0.025 (after Bonferroni correction) as compared with control. Mito-TEMPO is labeled as TEMPO.
Figure 6 Mito-TEMPO ameliorates hyperthermia-impaired platelet function. (A) Platelet aggregation was performed as described in Methods. Representative traces from three independent experiments are shown. (B and C) Washed platelets were incubated at the indicated temperatures for 3 h (B), or pre-incubated with Mito-TEMPO, GM6001 and solvent control at 37°C for 15 min, followed by incubation at 42°C for 3 h (C). Western blot was performed as described in Methods. (D and E) Washed platelets were incubated at indicated temperatures for 3 h (D), or pre-incubated without (control) or with Mito-TEMPO and solvent at 37°C for 15 min, and then incubated at 42°C for 3 h (E). Platelet adhesion was performed as described in Methods. The results shown are the mean ± SEM of cell number/mm2. *P<0.017 (after Bonferroni correction) as compared with RT, **P<0.025 (after Bonferroni correction) as compared with control. Mito-TEMPO is labeled as TEMPO.CC BY · PubMed Central
Figure 7 Hyperthermia decreases MnSOD protein levels and enzyme activity. (A and B) Washed platelets were incubated at the indicated temperatures for 3 h. Treated platelets were lysed, and ManSOD activity was measured using a commercially available SOD (A), or GPx4 (B) assay kits. *P<0.017 (after Bonferroni correction) as compared with RT. (C and D) Washed platelets were incubated at the indicated temperatures for 3 h. Treated platelets were lysed and analyzed by Western blot with anti-MnSOD (C), or anti-GPx4 (D). Actin levels demonstrated equal protein loading. Representative results of three independent experiments are presented.
Figure 7 Hyperthermia decreases MnSOD protein levels and enzyme activity. (A and B) Washed platelets were incubated at the indicated temperatures for 3 h. Treated platelets were lysed, and ManSOD activity was measured using a commercially available SOD (A), or GPx4 (B) assay kits. *P<0.017 (after Bonferroni correction) as compared with RT. (C and D) Washed platelets were incubated at the indicated temperatures for 3 h. Treated platelets were lysed and analyzed by Western blot with anti-MnSOD (C), or anti-GPx4 (D). Actin levels demonstrated equal protein loading. Representative results of three independent experiments are presented.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 155

Metadata

Authors
Wang, Z., Cai, F., Chen, X., Luo, M., Hu, L., & Lu, Y.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Shanghai University of Traditional Chinese Medicine (CN)
  • Anhui Medical University (CN)
Corresponding author
Lu, Yuan
Venue
PLoS ONE
Published
2013-09-04
Volume
8
Issue
9
Pages
e75044
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2011506319
Cited by
155
References
54
Citations by year
2026: 4 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 15 · 2017: 24 · 2016: 7 · 2015: 14 · 2014: 12
FWCI
7.89
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Shanghai
  • National Natural Science Foundation of China (81270650)
  • China Postdoctoral Science Foundation
  • Shanghai Municipal Education Commission
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
hyperthermia, platelet apoptosis, mitochondrial reactive oxygen species, MitoTEMPO, thrombocytopenia, manganese superoxide dismutase, cardiolipin peroxidation, malondialdehyde, platelet aggregation, platelet adhesion, oxidative stress, NADPH oxidase, nitric oxide synthase, cyclooxygenase, lipoxygenase
MeSH terms
Blood Platelets, Cardiolipins, Humans, Hyperthermia, Induced, Malondialdehyde, Mitochondria, Organophosphorus Compounds, Piperidines, Superoxides, Superoxide Dismutase, Lipid Peroxidation, Apoptosis, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis. https://app.cochat.ai/papers/10.1371/journal.pone.0075044
The paper
Wang, Z., Cai, F., Chen, X., Luo, M., Hu, L., & Lu, Y. (2013). The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis. PLoS ONE. https://doi.org/10.1371/journal.pone.0075044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.